Calmol 4 Suppository
FDA Label NDC 67492-104

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Resical Inc. for the product Calmol 4 (NDC 67492-104). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredients (in each suppository), purpose, uses, warnings, when using this product, stop use and ask doctor if, if pregnant or breast-feeding,, keep out of reach of children., and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Warnings

For rectal use only

* Please review the disclaimer below.